+ Watch THOR
on My Watchlist
The Company manufactures, develops and markets medical devices used for circulatory support.
long term buy at $33, 1yr target $45, 5yr EPS growth 27%
Thoratec Heartmate II devices say an increase in pump clots and death. Initial FDA reports were of clotting in about 1.2% .. which was true for a while.. during 2012 - for some unknown reasons the clot rate has shot up to 9% or higher depending on who's numbers you use. FDA investigation to pursue I would say.. and there are already class action lawsuits being filed due to the deaths.
THOR has just recently been approved to market the Heartmate ll pump for destination cardiac patients. This allows hope for many thousands of cardiac patients who might have less than a year to live and who are not elgible for or waiting for a transplant.
Solid growth company will outperform the S&P
LT Growth: 24%EPS Surp: Pos last 2 qtrsMF: +Large Volume IncreaeInsight, Driehaus, Fid Contra, Veredus, Calamos, Lord Abbett,Emerald, Kopp, NCM=BUY!
Expect takeover by MDT
another strong biotech company thats well run
People will have bad hearts. Thanks McDonalds
highlighted in IBD Tech. says way ahead of competition in heart pumps. sounds interesting.
This company is a lottery ticket but it's priced like the drawing is already complete. Institutions disposed 3% of their holdings last quarter; insiders acquiring (non open market) and doing same. Why bother with this?
Long term play on aging population.
Increasing medicare coverage that will allow more hospitals to implant the device, improved new product on the verge of approval, best in class.
well managed; great performer over past few years
BTT and DT market have tremendous potential. Will shoot up probably beginning July 2007. Strong potential for a takeover by another company. WIll see $50+ by the end of 2007, if not taken over earlier at a hefty premium.
Totally robotic heart implant FDA approved. new model in testing,should be approved by year end
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions